How much is the current price of each box of Ensartinib capsules?

Ensartinib is an ALK inhibitor developed and produced by China's local pharmaceutical company Betta Pharmaceuticals. It is mainly used to treat ALK-positive non-small cell lung cancer (NSCLC) patients. Since its launch, the drug has attracted the attention of clinicians and patients due to its clear efficacy, domestic status and medical insurance support. As a domestic innovative targeted drug, ensartinib has successfully filled some domestic treatment gaps.

In terms of price, up to now, the retail price of ensartinib in domestic pharmacies or hospitals is about more than 1,000 yuan per box. The specific price will fluctuate slightly according to specifications and regions. Taking the commonly used 100mg For smaller sizes, such as 25mg

Thanks to the support of the national medical insurance policy, ensartinib has been included in the national medical insurance catalog and falls within the scope of Category B reimbursement. According to the medical insurance reimbursement ratios in different provinces and cities, patients' final out-of-pocket expenses are significantly reduced. In some areas, the out-of-pocket price after reimbursement can be as low as 600–900yuan/ box, which greatly reduces the financial burden of long-term medication patients. This medicine can be prescribed in hospitals designated by medical insurance and some online pharmacy platforms.

In general, ensartinib has many advantages such as stable efficacy, moderate price, and reimbursement by medical insurance. It is currently a relatively accessible treatment option for patients with ALK positive lung cancer. It is recommended that patients take medicines on time under the guidance of professional doctors and choose regular pharmacies or hospitals to purchase medicines to ensure the quality of medicines and enjoy the complete protection of medical insurance policies.

Reference materials:https://www.drugs.com/